Nicholas Faberowski, MD
Ophthalmology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 19
- 4 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
19 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Faberowski’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
19 of 19 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
State licence records
1 licence
- Colorado DR.44086Physician · since 2005 · expires 2017-04-30Specialty on the licence: OpthamologyExpiredNo board action on this licenceCheck it with the stateWhat they told the state about themselves
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$53,233
Medicare paid this office $53,233 for 252 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of cataract with insertion of prosthetic lens | 47 | $26,232 | $504 |
| Established patient complete exam of visual system | 131 | $7,485 | $53 |
| Established patient problem focused exam of visual system | 85 | $5,027 | $41 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $3,512 | $319 |
| Imaging of optic nerve | 64 | $1,105 | $17 |
See all 9 services
| Removal of cataract with insertion of prosthetic lens | 47 | $26,232 | $504 |
| Established patient complete exam of visual system | 131 | $7,485 | $53 |
| Established patient problem focused exam of visual system | 85 | $5,027 | $41 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $3,512 | $319 |
| Imaging of optic nerve | 64 | $1,105 | $17 |
| New patient complete exam of visual system | 20 | $1,082 | $54 |
| Ultrasound scan to determine eye length and lens power | 30 | $779 | $26 |
| New patient problem focused exam of visual system | 15 | $498 | $33 |
| Imaging of retina | 15 | $304 | $20 |
Procedures Medicare counted
| Cataract surgery | 62 | More than 67% of doctors who do this |
Who their Medicare patients are
252 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 13% · Women 54% · Also on Medicaid 85% · Health risk score 1.67. Sicker patients than 9 in 10 peers; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 66% · Chronic kidney disease 27% · Coronary heart disease 19% · Heart failure 17% · Depression 15% · Atrial fibrillation 12% · Cancer 10% · COPD 8% · Dementia 6% · Stroke 6%.
The office billed $788,011, Medicare allowed $73,803 and paid $53,233; for 512 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 252 | 512 | 73 | 1.67 | $788,011 | $53,233 |
| 2023 | 246 | 578 | 73 | 1.63 | $856,912 | $60,691 |
| 2022 | 275 | 548 | 72 | 1.46 | $810,753 | $57,205 |
| 2021 | 244 | 505 | 73 | 1.84 | $757,705 | $55,343 |
| 2020 | 266 | 498 | 72 | 1.92 | $668,770 | $51,251 |
| 2019 | 344 | 743 | 72 | 1.70 | $801,327 | $82,001 |
| 2018 | 370 | 838 | 72 | 1.78 | $756,167 | $84,821 |
| 2017 | 330 | 659 | 71 | 1.64 | $676,239 | $84,535 |
| 2016 | 183 | 322 | 69 | 1.53 | $141,246 | $34,097 |
| 2015 | 243 | 441 | 67 | 1.68 | $211,736 | $51,833 |
| 2014 | 278 | 498 | 68 | 1.59 | $245,704 | $53,775 |
| 2013 | 293 | 510 | 68 | 1.48 | $232,006 | $53,199 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Removal of cataract with insertion of prosthetic lens | 52 | $31,130 | $519 |
| Established patient complete exam of visual system | 134 | $7,346 | $51 |
| Established patient problem focused exam of visual system | 80 | $6,050 | $42 |
| Removal of recurring cataract in lens capsule using a laser | 13 | $4,588 | $328 |
| New patient complete exam of visual system | 17 | $1,345 | $79 |
| Ultrasound scan to determine eye length and lens power | 51 | $1,326 | $26 |
| Imaging of optic nerve | 55 | $944 | $17 |
| Imaging of retina | 18 | $406 | $21 |
| Exam of visual field with extended testing | 16 | $386 | $24 |
| Exam of the internal drainage system of eye | 13 | $205 | $16 |
2022: 9 services
| Removal of cataract with insertion of prosthetic lens | 58 | $34,955 | $538 |
| Established patient complete exam of visual system | 148 | $7,625 | $50 |
| Established patient problem focused exam of visual system | 88 | $5,225 | $39 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $3,393 | $308 |
| Ultrasound scan to determine eye length and lens power | 56 | $1,558 | $28 |
| Imaging of optic nerve | 60 | $1,008 | $17 |
| Exam of visual field with extended testing | 24 | $549 | $23 |
| Imaging of retina | 16 | $315 | $20 |
| Ct scan of cornea | 12 | $221 | $18 |
2021: 8 services
| Removal of cataract with insertion of prosthetic lens | 47 | $29,683 | $540 |
| Established patient complete exam of visual system | 148 | $7,747 | $49 |
| Established patient problem focused exam of visual system | 67 | $3,344 | $38 |
| Imaging of optic nerve | 60 | $863 | $14 |
| Ultrasound scan to determine eye length and lens power | 38 | $822 | $22 |
| Exam of visual field with extended testing | 23 | $515 | $22 |
| Measurement of corneal curvature and depth of eye | 19 | $445 | $19 |
| Imaging of retina | 16 | $393 | $23 |
2020: 6 services
| Removal of cataract with insertion of prosthetic lens | 44 | $24,961 | $531 |
| Established patient complete exam of visual system | 174 | $8,826 | $48 |
| Established patient problem focused exam of visual system | 93 | $4,314 | $35 |
| Ultrasound scan to determine eye length and lens power | 31 | $924 | $30 |
| Imaging of optic nerve | 46 | $824 | $18 |
| Exam of visual field with extended testing | 11 | $269 | $24 |
2019: 11 services
| Removal of cataract with insertion of prosthetic lens | 56 | $36,782 | $603 |
| Established patient complete exam of visual system | 170 | $9,693 | $53 |
| Established patient problem focused exam of visual system | 135 | $7,731 | $41 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 13 | $5,345 | $214 |
| Removal of recurring cataract in lens capsule using a laser | 12 | $3,899 | $300 |
| New patient complete exam of visual system | 25 | $1,541 | $62 |
| Exam of visual field with extended testing | 56 | $1,488 | $25 |
| Imaging of optic nerve | 60 | $1,121 | $18 |
| Measurement of corneal curvature and depth of eye | 33 | $936 | $28 |
| Ultrasound scan to determine eye length and lens power | 20 | $664 | $30 |
| Exam of the internal drainage system of eye | 17 | $223 | $13 |
2018: 11 services
| Removal of cataract with insertion of prosthetic lens | 45 | $30,840 | $605 |
| Complex removal of cataract with insertion of prosthetic lens | 24 | $17,461 | $728 |
| Established patient complete exam of visual system | 199 | $12,104 | $57 |
| Established patient problem focused exam of visual system | 128 | $6,549 | $41 |
| New patient complete exam of visual system | 34 | $2,034 | $60 |
| Measurement of corneal curvature and depth of eye | 71 | $1,853 | $25 |
| Exam of visual field with extended testing | 76 | $1,683 | $22 |
| Imaging of optic nerve | 91 | $1,627 | $17 |
| Exam of the internal drainage system of eye | 27 | $397 | $15 |
| Imaging of retina | 19 | $319 | $17 |
| Ultrasound scan of cornea to determine thickness | 16 | $109 | $7 |
2017: 13 services
| Complex removal of cataract with insertion of prosthetic lens | 34 | $26,144 | $726 |
| Removal of cataract with insertion of prosthetic lens | 35 | $22,345 | $604 |
| Established patient complete exam of visual system | 148 | $9,931 | $61 |
| Established patient problem focused exam of visual system | 103 | $4,773 | $40 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 13 | $4,423 | $221 |
| Exam of visual field with extended testing | 53 | $1,309 | $23 |
| New patient complete exam of visual system | 14 | $1,198 | $86 |
| Exam of the internal drainage system of eye | 42 | $766 | $18 |
| Imaging of optic nerve | 36 | $755 | $19 |
| Imaging of retina | 37 | $677 | $18 |
| Ultrasound scan to determine eye length and lens power | 21 | $620 | $28 |
| Measurement of corneal curvature and depth of eye | 17 | $532 | $30 |
| Short return visit (20+ min) | 12 | $456 | $33 |
2016: 10 services
| Removal of cataract with insertion of prosthetic lens | 21 | $12,275 | $491 |
| Complex removal of cataract with insertion of prosthetic lens | 17 | $11,025 | $649 |
| Established patient problem focused exam of visual system | 45 | $1,549 | $30 |
| Short return visit (20+ min) | 42 | $1,421 | $32 |
| Return visit (30+ min) | 30 | $1,269 | $42 |
| Established patient complete exam of visual system | 33 | $1,243 | $37 |
| Exam of visual field with extended testing | 21 | $313 | $14 |
| Short return visit | 13 | $221 | $16 |
| Imaging of optic nerve | 17 | $218 | $13 |
| Ultrasound scan to determine eye length and lens power | 14 | $199 | $14 |
2015: 13 services
| Removal of cataract with insertion of prosthetic lens | 34 | $19,230 | $506 |
| Complex removal of cataract with insertion of prosthetic lens | 13 | $7,983 | $614 |
| Established patient complete exam of visual system | 83 | $3,919 | $45 |
| Removal of recurring cataract in lens capsule using a laser | 12 | $3,458 | $247 |
| Established patient problem focused exam of visual system | 57 | $2,566 | $35 |
| Return visit (30+ min) | 38 | $1,983 | $51 |
| New patient complete exam of visual system | 26 | $1,567 | $60 |
| Short return visit (20+ min) | 21 | $692 | $33 |
| Measurement of corneal curvature and depth of eye | 15 | $659 | $24 |
| New patient visit (30+ min) | 12 | $453 | $38 |
| Ultrasound scan to determine eye length and lens power | 17 | $373 | $22 |
| Exam of visual field with extended testing | 15 | $335 | $22 |
| Imaging of optic nerve | 15 | $290 | $19 |
2014: 12 services
| Removal of cataract with insertion of prosthetic lens | 37 | $23,215 | $516 |
| Established patient complete exam of visual system | 71 | $4,257 | $58 |
| Established patient problem focused exam of visual system | 83 | $3,712 | $36 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $3,192 | $266 |
| New patient complete exam of visual system | 38 | $2,575 | $68 |
| Short return visit (20+ min) | 53 | $1,967 | $34 |
| Exam of visual field with extended testing | 23 | $479 | $21 |
| Imaging of optic nerve | 19 | $456 | $23 |
| New patient problem focused exam of visual system | 14 | $433 | $31 |
| Ultrasound scan to determine eye length and lens power | 15 | $410 | $26 |
| Imaging of retina | 11 | $260 | $24 |
| Exam of the internal drainage system of eye | 11 | $192 | $17 |
2013: 13 services
| Removal of cataract with insertion of prosthetic lens | 32 | $19,525 | $514 |
| Complex removal of cataract with insertion of prosthetic lens | 13 | $8,377 | $644 |
| Established patient complete exam of visual system | 82 | $3,854 | $46 |
| Removal of recurring cataract in lens capsule using a laser | 13 | $3,242 | $249 |
| New patient complete exam of visual system | 54 | $3,204 | $59 |
| Established patient problem focused exam of visual system | 44 | $1,531 | $34 |
| Return visit (30+ min) | 25 | $1,344 | $54 |
| New patient problem focused exam of visual system | 35 | $1,061 | $30 |
| Short return visit (20+ min) | 22 | $891 | $37 |
| Short return visit | 42 | $875 | $15 |
| Measurement of corneal curvature and depth of eye | 22 | $744 | $23 |
| Imaging of optic nerve | 23 | $467 | $19 |
| Exam of visual field with extended testing | 14 | $332 | $22 |
Medicaid work
$46,647 in 2024
Medicaid paid $46,647 for 2,893 billed services this clinician did in 2024, up to 58 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 338 | $36,265 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 490 | $4,604 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 316 | $2,551 |
| Service | 72 | $1,141 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 145 | $804 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 53 | $589 |
| Ophthalmic biometry by A-scan ultrasound echography with intraocular lens power calculation | 62 | $266 |
| Injection, adrenalin, epinephrine, 0.1 mg | 185 | $201 |
| Injection, dexamethasone sodium phosphate, 1 mg | 190 | $116 |
| INTRM OPH EXAM NEW PATIENT | 12 | $77 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 71 | $32 |
| Service | 959 | $0 |
| 2024 | 2,893 | 12 | 58 | $46,647 |
| 2023 | 3,886 | 14 | 54 | $53,817 |
| 2022 | 852 | 5 | 41 | $17,315 |
| 2021 | 224 | 6 | 21 | $13,079 |
| 2020 | 649 | 4 | 43 | $13,901 |
| 2019 | 881 | 7 | 45 | $15,616 |
| 2018 | 1,624 | 16 | 48 | $19,205 |
See the largest Medicaid services in earlier years
2023
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 369 | $44,849 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 511 | $3,441 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 443 | $2,802 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 221 | $1,067 |
| Ophthalmic biometry by A-scan ultrasound echography with intraocular lens power calculation | 117 | $424 |
| Service | 72 | $396 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 38 | $246 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 50 | $218 |
| Injection, adrenalin, epinephrine, 0.1 mg | 213 | $194 |
| Injection, dexamethasone sodium phosphate, 1 mg | 214 | $108 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 109 | $54 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 13 | $18 |
2022
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 89 | $11,764 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 301 | $2,761 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 295 | $1,812 |
| Ophthalmic biometry by A-scan ultrasound echography with intraocular lens power calculation | 92 | $528 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 75 | $451 |
2021
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 86 | $12,209 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 26 | $314 |
| Ophthalmic biometry by A-scan ultrasound echography with intraocular lens power calculation | 21 | $205 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 35 | $179 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 44 | $92 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 12 | $82 |
2020
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 59 | $9,696 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 289 | $2,826 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 265 | $1,221 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 36 | $158 |
2019
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 72 | $11,297 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 414 | $3,004 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 278 | $868 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 52 | $246 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 38 | $141 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 12 | $61 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 15 | $0 |
2018
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 96 | $10,242 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 426 | $3,408 |
| XCAPSL CTRC RMVL CPLX WO ECP | 24 | $1,685 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 337 | $1,407 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 85 | $686 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 95 | $514 |
| Service | 19 | $439 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 93 | $304 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 75 | $217 |
| Service | 58 | $131 |
| GONIOSCOPY | 16 | $66 |
| Blood glucose (sugar) level | 27 | $54 |
Drugs they prescribed that Part D paid
$93,307
Pharmacies billed $93,307 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,813) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
2,250 generic and 563 brand-name prescriptions · $93,307 in drug cost · 24 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Brimonidine | 264 | $11,984 | $45 |
| Prednisolone Acetate | 229 | $10,212 | $45 |
| Latanoprost | 1,256 | $9,759 | $8 |
| Rhopressa | 26 | $7,756 | $298 |
| Restasis | 14 | $7,719 | $551 |
See all 18 drugs
| Brimonidine | 264 | $11,984 | $45 |
| Prednisolone Acetate | 229 | $10,212 | $45 |
| Latanoprost | 1,256 | $9,759 | $8 |
| Rhopressa | 26 | $7,756 | $298 |
| Restasis | 14 | $7,719 | $551 |
| Travoprost | 56 | $5,256 | $94 |
| Brinzolamide | 28 | $4,791 | $171 |
| Cyclosporine | 15 | $3,936 | $262 |
| Vyzulta | 15 | $3,341 | $223 |
| Timolol Maleate | 392 | $3,052 | $8 |
| Dorzolamide | 125 | $2,035 | $16 |
| Dorzolamide-Timolol | 121 | $1,751 | $14 |
| Tobramycin-Dexamethasone | 41 | $1,375 | $34 |
| Moxifloxacin | 39 | $891 | $23 |
| Ketorolac Tromethamine | 39 | $562 | $14 |
| Erythromycin | 36 | $326 | $9 |
| Neomycin-Polymyxin-Dexameth | 17 | $187 | $11 |
| Doxycycline Monohydrate | 14 | $185 | $13 |
Year by year
| 2024 | 2,813 | 383 | 0% (0) | 20% | $93,307 |
| 2023 | 2,670 | 400 | 0% (0) | 22% | $127,049 |
| 2022 | 2,572 | 386 | 0% (0) | 23% | $143,574 |
| 2021 | 2,554 | 373 | 0% (0) | 25% | $136,984 |
| 2020 | 2,578 | 369 | 0% (0) | 24% | $130,100 |
| 2019 | 2,553 | 432 | 0% (0) | 26% | $144,229 |
| 2018 | 2,314 | 405 | 0% (0) | 33% | $125,060 |
| 2017 | 2,353 | 498 | 0% (0) | 40% | $117,805 |
| 2016 | 2,749 | 532 | None | 40% | $97,888 |
| 2015 | 2,492 | 387 | None | None | $75,706 |
| 2014 | 2,069 | 371 | None | None | $70,235 |
| 2013 | 1,988 | 357 | 0% (0) | 35% | $52,993 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Brimonidine | 246 | $19,432 | $79 |
| Latanoprost | 1,173 | $15,497 | $13 |
| Restasis | 27 | $13,316 | $493 |
| Prednisolone Acetate | 234 | $13,132 | $56 |
| Lumigan | 28 | $9,878 | $353 |
| Travoprost | 65 | $7,635 | $117 |
| Cyclosporine | 19 | $7,333 | $386 |
| Alphagan P | 14 | $6,529 | $466 |
| Dorzolamide | 122 | $4,510 | $37 |
| Timolol Maleate | 346 | $4,387 | $13 |
| Tobradex | 12 | $3,396 | $283 |
| Dorzolamide-Timolol | 123 | $2,842 | $23 |
| Tobramycin-Dexamethasone | 44 | $2,505 | $57 |
| Dorzolamide-Timolol | 12 | $1,541 | $128 |
| Erythromycin | 53 | $633 | $12 |
| Moxifloxacin | 11 | $480 | $44 |
| Neomycin-Polymyxin-Dexameth | 22 | $342 | $16 |
| Diclofenac | 20 | $280 | $14 |
| Ketorolac Tromethamine | 15 | $266 | $18 |
2022: 20 drugs
| Brimonidine | 197 | $21,172 | $107 |
| Restasis | 46 | $21,089 | $458 |
| Latanoprost | 1,133 | $14,838 | $13 |
| Travoprost | 49 | $12,935 | $264 |
| Prednisolone Acetate | 217 | $12,001 | $55 |
| Alphagan P | 24 | $10,167 | $424 |
| Lumigan | 18 | $9,866 | $548 |
| Cyclosporine | 14 | $6,678 | $477 |
| Tobradex | 25 | $5,994 | $240 |
| Dorzolamide | 148 | $5,597 | $38 |
| Timolol Maleate | 332 | $4,539 | $14 |
| Dorzolamide-Timolol | 117 | $2,661 | $23 |
| Tobramycin-Dexamethasone | 26 | $2,190 | $84 |
| Acetazolamide | 12 | $1,397 | $116 |
| Azathioprine | 11 | $1,217 | $111 |
| Moxifloxacin | 21 | $802 | $38 |
| Ketorolac Tromethamine | 39 | $608 | $16 |
| Diclofenac | 17 | $353 | $21 |
| Erythromycin | 29 | $323 | $11 |
| Neomycin-Polymyxin-Dexameth | 16 | $273 | $17 |
2021: 17 drugs
| Restasis | 48 | $23,164 | $483 |
| Brimonidine | 165 | $16,463 | $100 |
| Travoprost | 61 | $15,795 | $259 |
| Latanoprost | 1,135 | $15,305 | $13 |
| Prednisolone Acetate | 166 | $10,767 | $65 |
| Alphagan P | 20 | $8,392 | $420 |
| Tobradex | 28 | $6,523 | $233 |
| Dorzolamide | 123 | $5,282 | $43 |
| Lumigan | 12 | $5,133 | $428 |
| Timolol Maleate | 388 | $5,056 | $13 |
| Tobramycin-Dexamethasone | 44 | $4,081 | $93 |
| Dorzolamide-Timolol | 117 | $3,284 | $28 |
| Ketorolac Tromethamine | 28 | $1,319 | $47 |
| Diclofenac | 28 | $559 | $20 |
| Neomycin-Polymyxin-Dexameth | 32 | $445 | $14 |
| Erythromycin | 35 | $376 | $11 |
| Flurbiprofen | 11 | $362 | $33 |
2020: 21 drugs
| Brimonidine | 176 | $14,151 | $80 |
| Prednisolone Acetate | 212 | $14,142 | $67 |
| Restasis | 36 | $13,937 | $387 |
| Travoprost | 56 | $13,904 | $248 |
| Latanoprost | 1,061 | $13,613 | $13 |
| Travatan Z | 33 | $7,970 | $242 |
| Tobradex | 29 | $6,740 | $232 |
| Alphagan P | 18 | $6,470 | $359 |
| Dorzolamide | 139 | $5,304 | $38 |
| Lumigan | 11 | $4,411 | $401 |
| Tobramycin-Dexamethasone | 44 | $4,260 | $97 |
| Dorzolamide-Timolol | 86 | $3,980 | $46 |
| Timolol Maleate | 352 | $3,902 | $11 |
| Acetazolamide | 20 | $1,693 | $85 |
| Ketorolac Tromethamine | 51 | $1,044 | $20 |
| Erythromycin | 66 | $770 | $12 |
| Flurbiprofen | 16 | $640 | $40 |
| Doxycycline Monohydrate | 20 | $596 | $30 |
| Diclofenac | 35 | $557 | $16 |
| Olopatadine | 14 | $482 | $34 |
| Neomycin-Polymyxin-Dexameth | 26 | $406 | $16 |
2019: 22 drugs
| Travatan Z | 106 | $28,558 | $269 |
| Prednisolone Acetate | 271 | $15,926 | $59 |
| Restasis | 33 | $15,579 | $472 |
| Latanoprost | 997 | $12,801 | $13 |
| Alphagan P | 35 | $11,522 | $329 |
| Brimonidine | 172 | $11,375 | $66 |
| Lumigan | 20 | $6,580 | $329 |
| Dorzolamide | 173 | $6,444 | $37 |
| Tobradex | 28 | $6,395 | $228 |
| Combigan | 11 | $5,245 | $477 |
| Tobramycin-Dexamethasone | 51 | $4,361 | $86 |
| Azopt | 12 | $4,072 | $339 |
| Dorzolamide-Timolol | 81 | $3,594 | $44 |
| Timolol Maleate | 311 | $2,503 | $8 |
| Olopatadine | 18 | $1,317 | $73 |
| Acetazolamide | 14 | $1,094 | $78 |
| Doxycycline Monohydrate | 14 | $660 | $47 |
| Erythromycin | 50 | $639 | $13 |
| Ketorolac Tromethamine | 40 | $574 | $14 |
| Flurbiprofen | 13 | $427 | $33 |
| Neomycin-Polymyxin-Dexameth | 28 | $424 | $15 |
| Diclofenac | 32 | $402 | $13 |
2018: 21 drugs
| Travatan Z | 140 | $32,945 | $235 |
| Prednisolone Acetate | 205 | $13,079 | $64 |
| Brimonidine | 136 | $10,736 | $79 |
| Latanoprost | 910 | $10,716 | $12 |
| Alphagan P | 40 | $10,358 | $259 |
| Restasis | 23 | $10,094 | $439 |
| Lumigan | 35 | $8,434 | $241 |
| Tobradex | 20 | $4,183 | $209 |
| Dorzolamide | 160 | $3,492 | $22 |
| Tobramycin-Dexamethasone | 41 | $3,331 | $81 |
| Pazeo | 11 | $2,567 | $233 |
| Timolol Maleate | 290 | $2,267 | $8 |
| Olopatadine | 25 | $1,338 | $54 |
| Ketorolac Tromethamine | 59 | $1,090 | $18 |
| Doxycycline Monohydrate | 16 | $1,057 | $66 |
| Dorzolamide-Timolol | 47 | $875 | $19 |
| Diclofenac | 27 | $321 | $12 |
| Doxycycline Hyclate | 15 | $247 | $16 |
| Erythromycin | 21 | $237 | $11 |
| Neomycin-Polymyxin-Dexameth | 14 | $212 | $15 |
| Flurbiprofen | 21 | $193 | $9 |
2017: 19 drugs
| Travatan Z | 143 | $25,110 | $176 |
| Brimonidine | 145 | $20,372 | $140 |
| Alphagan P | 68 | $14,082 | $207 |
| Prednisolone Acetate | 280 | $13,464 | $48 |
| Latanoprost | 849 | $10,406 | $12 |
| Lumigan | 35 | $6,131 | $175 |
| Tobramycin-Dexamethasone | 44 | $3,527 | $80 |
| Dorzolamide | 128 | $2,848 | $22 |
| Pataday | 17 | $2,555 | $150 |
| Timolol Maleate | 288 | $1,983 | $7 |
| Olopatadine | 35 | $1,675 | $48 |
| Doxycycline Monohydrate | 17 | $814 | $48 |
| Dorzolamide-Timolol | 37 | $717 | $19 |
| Ketorolac Tromethamine | 40 | $706 | $18 |
| Diclofenac | 41 | $673 | $16 |
| Flurbiprofen | 76 | $511 | $7 |
| Doxycycline Hyclate | 16 | $433 | $27 |
| Neomycin-Polymyxin-Dexameth | 19 | $308 | $16 |
| Erythromycin | 18 | $179 | $10 |
2016: 20 drugs
| Brimonidine | 166 | $15,971 | $96 |
| Latanoprost | 1,015 | $11,995 | $12 |
| Travatan Z | 78 | $11,380 | $146 |
| Prednisolone Acetate | 216 | $10,985 | $51 |
| Tobramycin-Dexamethasone | 98 | $7,589 | $77 |
| Alphagan P | 56 | $6,036 | $108 |
| Lumigan | 54 | $5,005 | $93 |
| Combigan | 13 | $3,531 | $272 |
| Timolol Maleate | 394 | $2,926 | $7 |
| Diclofenac | 161 | $2,525 | $16 |
| Dorzolamide | 100 | $2,225 | $22 |
| Acetazolamide | 13 | $1,980 | $152 |
| Tobradex St | 15 | $1,310 | $87 |
| Neomycin-Polymyxin-Dexameth | 78 | $1,228 | $16 |
| Erythromycin | 87 | $1,003 | $12 |
| Ofloxacin | 25 | $446 | $18 |
| Dorzolamide-Timolol | 20 | $305 | $15 |
| Minocycline | 27 | $238 | $9 |
| Doxycycline Hyclate | 12 | $206 | $17 |
| Flurbiprofen | 19 | $126 | $7 |
2015: 18 drugs
| Latanoprost | 985 | $12,170 | $12 |
| Brimonidine | 117 | $10,582 | $90 |
| Tobramycin-Dexamethasone | 94 | $8,455 | $90 |
| Travatan Z | 59 | $6,491 | $110 |
| Tobradex St | 55 | $5,122 | $93 |
| Prednisolone Acetate | 105 | $4,955 | $47 |
| Alphagan P | 41 | $4,403 | $107 |
| Diclofenac | 195 | $2,921 | $15 |
| Lumigan | 37 | $2,631 | $71 |
| Timolol Maleate | 329 | $2,363 | $7 |
| Dorzolamide | 94 | $2,255 | $24 |
| Acetazolamide | 14 | $2,128 | $152 |
| Erythromycin | 99 | $1,332 | $13 |
| Neomycin-Polymyxin-Dexameth | 79 | $1,118 | $14 |
| Doxycycline Hyclate | 37 | $1,112 | $30 |
| Dorzolamide-Timolol | 21 | $555 | $26 |
| Ofloxacin | 16 | $246 | $15 |
| Doxycycline Monohydrate | 17 | $237 | $14 |
2014: 17 drugs
| Brimonidine | 94 | $9,903 | $105 |
| Prednisolone Acetate | 178 | $9,489 | $53 |
| Latanoprost | 673 | $8,932 | $13 |
| Tobramycin-Dexamethasone | 99 | $6,372 | $64 |
| Lumigan | 48 | $4,792 | $100 |
| Travatan Z | 41 | $3,885 | $95 |
| Alphagan P | 23 | $3,770 | $164 |
| Diclofenac | 220 | $2,996 | $14 |
| Timolol Maleate | 282 | $2,153 | $8 |
| Acetazolamide | 17 | $2,126 | $125 |
| Patanol | 11 | $1,786 | $162 |
| Dorzolamide | 38 | $1,310 | $34 |
| Doxycycline Hyclate | 25 | $1,291 | $52 |
| Erythromycin | 88 | $1,148 | $13 |
| Ofloxacin | 86 | $887 | $10 |
| Dorzolamide-Timolol | 39 | $866 | $22 |
| Neomycin-Polymyxin-Dexameth | 41 | $640 | $16 |
2013: 16 drugs
| Latanoprost | 684 | $9,246 | $14 |
| Brimonidine | 82 | $9,134 | $111 |
| Lumigan | 64 | $5,758 | $90 |
| Prednisolone Acetate | 197 | $4,433 | $23 |
| Travatan Z | 63 | $3,876 | $62 |
| Tobramycin-Dexamethasone | 49 | $3,270 | $67 |
| Diclofenac | 230 | $3,242 | $14 |
| Timolol Maleate | 286 | $2,510 | $9 |
| Patanol | 17 | $2,357 | $139 |
| Alphagan P | 17 | $1,739 | $102 |
| Dorzolamide | 34 | $1,116 | $33 |
| Erythromycin | 76 | $951 | $13 |
| Neomycin-Polymyxin-Dexameth | 42 | $694 | $17 |
| Ofloxacin | 68 | $594 | $9 |
| Dorzolamide-Timolol | 18 | $487 | $27 |
| Acetazolamide | 15 | $289 | $19 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1073536157
- Licence
- CO 44086Colorado DR.44086: Expired
- Trained
- Duke University School of Medicine, 1989
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CO 68800878
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 751 S Bascom Ave, San Jose, CA, 95128
- NPI first listed
- 2006-07-26
- NPI last updated
- 2022-04-29
- NPI record certified
- 2022-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 751 S Bascom Ave, San Jose, CA, 95128